Providing access to risk prediction tools via the HL7 XML-formatted risk web service

Breast Cancer Research and Treatment

Volumn 140, Issue 1, 2013, Pages 187-193

  Chipman, Jonathan ^a   Drohan, Brian ^b   Blackford, Amanda ^c   Parmigiani, Giovanni ^a   Hughes, Kevin ^b   Bosinoff, Phil ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

BayesMendel; BRCAPRO; Colorectal Cancer Risk Assessment Tool; IBIS Breast Cancer Risk Evaluation Tool; Risk prediction; Risk service; Web service

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CLIENT SERVER APPLICATION; COLORECTAL CANCER; COMPUTER PREDICTION; COMPUTER PROGRAM; FAMILY HISTORY; HL7 XML FORMATTED RISK WEB SERVICE; INTERNET; PRIORITY JOURNAL; RISK ASSESSMENT;

ALGORITHMS; BREAST NEOPLASMS; FEMALE; HUMANS; INTERNET; PEDIGREE; RISK ASSESSMENT; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 84880267880     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2605-z     Document Type: Article

References (26)

1. Parmigiani G, Berry DA, Aguilar O (1998) Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158 (Pubitemid 28093844)
2. Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811-1814 (Pubitemid 351767200)
3. Tai YC, Chen S, Parmigiani G, Klein AP (2008) Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction. Breast Cancer Res 10(2):401
4. Katki HA, Blackford A, Chen S, Parmigiani G (2008) Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO. Stat Med 27(22):4532-4548
5. Katki HA (2007) Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13 (Pubitemid 46564014)
6. Chen S, Blackford A, Parmigiani G (2009) Tailoring BRCAPRO to Asian-Americans. J Clin Oncol 27(4):642-643
7. Biswas S, Tankhiwale N, Blackford A, Barrera AMG, Ready K, Lu K, Amos CI, Parmigiani G, Arun B (2012) Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat 133(1):347-355
8. Chen S, Wang W, Broman KW, Katki HA, Parmigiani G (2004) Bayes-Mendel: an R Environment for Mendelian Risk Prediction. Stat Appl Genet Mol Biol 3:Article21
9. CaGene [ http://www4.utsouthwestern.edu/breasthealth/cagene/ ]
10. HughesRiskApps [ http://www.hughesriskapps.com/ ]
11. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS (2009) Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J 15(2):155-162
12. Health Level Seven International [ http://www.hl7.org/ ]
13. Tomcat [ http://www.apache.org ]
14. To Obtain Risk Service [ http://bcb.dfci.harvard.edu/bayesmendel/ riskservice.php ]
15. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643-646 (Pubitemid 37310920)
16. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130 (Pubitemid 36530000)
17. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 Penetrance. J Clin Oncol 25(11):1329-1333 (Pubitemid 46706879)
18. Parmigiani G, Chen S, Iversen ES Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 14(7):441-450 (Pubitemid 351664516)
19. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber S, Euhus D, Kinzler K, Jass J, Gallinger S, Lindor N, Casey G, Ellis N, Giardiello F, Offit K, Parmigiani G, The Colon Cancer Family Registry (2007) Prediction of germline mutations and cancer risk in the lynch syndrome. JAMA 296(12):1479-1487
20. Wang W, Chen S, Brune K, Hruban R, Parmigiani G, Klein A (2007) PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 25(11):1417-1422 (Pubitemid 46706891)
21. Wang W, Niendorf K, Patel D, Blackford A, Marroni F, Sober AJ, Parmigiani G, Tsao H (2010) Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. Cancer Res 70(2):552-559
22. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111-1130 (Pubitemid 38477070)
23. Boughey J, Hartmann L, Anderson S, Degnim A, Vierkant R, Reynolds C, Frost M, Pankratz V (2010) Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 28(22):3591-3596
24. Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann B, Pee D, Gail MH, Pfeiffer RM (2009) A colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 27(5):686-693
25. Risk Service Demo [ http://bayesmendel.dfci.harvard.edu/risk ]
26. BayesMendel Lab [ http://bcb.dfci.harvard.edu/bayesmendel/index.php ]